Related references
Note: Only part of the references are listed.MRP3-Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression
Elisa Lozano et al.
HEPATOLOGY (2020)
The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis Through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway
Wenbo Ma et al.
HEPATOLOGY (2020)
JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma
Elisa Manieri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma
Francisco Javier Cubero et al.
HEPATOLOGY COMMUNICATIONS (2020)
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma
Marina Barcena-Varela et al.
HEPATOLOGY (2019)
Biliary tract cancers: current knowledge, clinical candidates and future challenges
Noor-ul-Ain Tariq et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy
Elisa Lozano et al.
HEPATOLOGY (2019)
UHRF1 is regulated by miR-124-3p and promotes cell proliferation in intrahepatic cholangiocarcinoma
Mengxuan Zhu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The SIRT2/cMYC Pathway Inhibit Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming
Lei Xu et al.
NEOPLASIA (2019)
Methylation Dynamics of RASSF1A and Its Impact on Cancer
Giorgio Malpeli et al.
CANCERS (2019)
Metabolic rearrangements in primary liver cancers: cause and consequences
Letizia Satriano et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Epigenetic mechanism and target therapy of UHRF1 protein complex in malignancies
Busheng Xue et al.
ONCOTARGETS AND THERAPY (2019)
Epigenome Remodeling in Cholangiocarcinoma
Colm J. O'Rourke et al.
TRENDS IN CANCER (2019)
Cholangiocarcinoma - evolving concepts and therapeutic strategies
Sumera Rizvi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Chemoresistance and chemosensitization in cholangiocarcinoma
Jose J. G. Marin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Squalene epoxidase as a promising metabolic target in cancer treatment
Gabriella Cirmena et al.
CANCER LETTERS (2018)
The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer
Christian Mayr et al.
HUMAN PATHOLOGY (2018)
FBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinoma
Bo Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/beta-catenin pathway
Wei Zhao et al.
LIFE SCIENCES (2018)
MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis
William B. Tu et al.
CANCER CELL (2018)
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma
Maite Merino-Azpitarte et al.
JOURNAL OF HEPATOLOGY (2017)
Methylation of DNA Ligase 1 by G9a/GLP Recruits UHRF1 to Replicating DNA and Regulates DNA Methylation
Laure Ferry et al.
MOLECULAR CELL (2017)
Human primary liver cancer-derived organoid cultures for disease modeling and drug screening
Laura Broutier et al.
NATURE MEDICINE (2017)
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
Edurne San Jose-Eneriz et al.
NATURE COMMUNICATIONS (2017)
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (vol 18, pg 2780, 2017)
Farshad Farshidfar et al.
CELL REPORTS (2017)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma
Xueru Mu et al.
GASTROENTEROLOGY (2016)
Deregulated Methionine Adenosyltransferase α1, c-Myc, and Maf Proteins Together Promote Cholangiocarcinoma Growth in Mice and Humans
Heping Yang et al.
HEPATOLOGY (2016)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma
Hideki Suzuki et al.
DIGESTIVE AND LIVER DISEASE (2015)
Genomic spectra of biliary tract cancer
Hiromi Nakamura et al.
NATURE GENETICS (2015)
DNA methylation pathways and their crosstalk with histone methylation
Jiamu Du et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer
Fang Fang et al.
CLINICAL CANCER RESEARCH (2014)
Global Alterations of DNA Methylation in Cholangiocarcinoma Target the Wnt Signaling Pathway
Benjamin Goeppert et al.
HEPATOLOGY (2014)
Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
Chenfang Dong et al.
CANCER CELL (2013)
Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
Jesper B. Andersen et al.
GASTROENTEROLOGY (2012)
Recruitment of Coregulator G9a by Runx2 for Selective Enhancement or Suppression of Transcription
Daniel J. Purcell et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma
Yu-Chuen Huang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3K9 di-methylation levels are linked to tumor suppressor gene reactivation
R. J. Wozniak et al.
ONCOGENE (2007)
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells
ER Wood et al.
CANCER RESEARCH (2004)
Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma
N Wong et al.
JOURNAL OF HEPATOLOGY (2002)
Share Paper
